Z. David Wang

Z. David Wang is a pharmaceutical professional with extensive experience in clinical program management and project leadership across various companies. Currently serving as Senior Director, Head of Clinical Program and Portfolio at Kallyope since January 2023, Z. David Wang previously held roles such as Project Director at ADC Therapeutics, Director of Project Management at Esperion, and Director of Program Management at Eisai US. Significant contributions include leading the Zynlonta program at ADC Therapeutics and managing oncology drug development projects for Bayer Pharmaceuticals and Roche. Z. David Wang's academic credentials include a PhD in Pharmaceutical Sciences from the University of Kentucky College of Pharmacy, an MBA from Ivey Business School at Western University, and a BS in Genetics & Genetic Engineering from Fudan University.